Stocks›Healthcare›KRYS

KRYS

Krystal Biotech, Inc.

NasdaqResearch view

Healthcare · Biological Products, (No Diagnostic Substances) · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$10.0B

Enterprise Value$9.5B

Income$204.8M

Sales$389.1M

Book/sh$41.20

Cash/sh$16.77

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio9.56

Current Ratio9.95

Debt/Eq0.00

EPS (ttm)$6.84

EPS this Y128.0%

EPS past 3/5Y—

Sales past 3/5Y—

EPS Y/Y TTM128.0%

Sales Y/Y TTM33.9%

Shs Outstand29.60M

ROA15.4%

ROE16.8%

ROIC24.0%

Gross Margin—

Oper. Margin41.5%

Profit Margin52.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

2021

2022

$50.7M

2023

$290.5M

2024

$389.1M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$0	$0	$50.7M	$290.5M	$389.1M
Gross Profit	—	—	—	—	—
Operating Income	$-68.3M	$-145.2M	$-109.6M	$65.7M	$161.3M
Net Income	$-69.6M	$-140.0M	$10.9M	$89.2M	$204.8M
Diluted EPS	$-3.13	$-5.49	$0.39	$3.00	$6.84
Operating Cash Flow	$-47.9M	$-100.6M	$-88.8M	$123.4M	$200.9M
Free Cash Flow	$-116.3M	$-153.5M	$-100.6M	$119.2M	$188.9M